ELAVL1 and hepatocellular carcinoma: In addition, by competitively binding to the HuR protein, lncRNA ADORA2A-AS1 can inhibit the interaction between HuR and FSCN1 by downregulating the expression of FSCN1, subsequently repressing AKT signaling pathway activation, thereby restraining HCC progression11.